2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$6.82+$0.05 (+0.80%)
Price as of Jun 23, 2026 6:59 PM EDT- $722.7MMarket Cap
- 1,043.77%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$6.82+$0.05 (+0.80%)
Earnings Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 15.36% | ||
12-Month Momentum | 1,080.23% | ||
3-Month Risk Adjusted Momentum | 55.09% | ||
12-Month Risk Adjusted Momentum | 893.75% |
True Yield
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.46% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |